オオメ ユウスケ
OOME Yuusuke
大目 祐介 所属 医学部 医学科(東京女子医科大学病院) 職種 講師 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | A Multicenter Retrospective Study on Adjuvant S-1 Chemotherapy Versus Observation Following Major Hepatectomy for Perihilar Cholangiocarcinoma |
掲載誌名 | 正式名:Annals of surgical oncology 略 称:Ann Surg Oncol ISSNコード:15344681/10689265 |
掲載区分 | 国外 |
巻・号・頁 | 32(3),pp.1784-1794 |
著者・共著者 | HOSOKAWA Isamu, HIGUCHI Ryota, HOMMA Yuki, TAKASAKI Tsukasa, OME Yusuke, MATSUYAMA Ryusei, TAKANO Shigetsugu, UEMURA Shuichiro, YABUSHITA Yasuhiro, HONDA Goro, ENDO Itaru, OHTSUKA Masayuki |
発行年月 | 2025/03 |
概要 | BACKGROUND:The prognosis of perihilar cholangiocarcinoma (PHC) is poor even after curative resection, highlighting the need for effective adjuvant chemotherapy. The efficacy of adjuvant S-1 chemotherapy following major hepatectomy for PHC is unclear, and thus the aim of this study was to elucidate this.METHODS:Consecutive patients with PHC who underwent major hepatectomy (hemihepatectomy or trisectionectomy extending to segment 1 with extrahepatic bile duct resection) at three high-volume centers in Japan from 2007 to 2020 were retrospectively evaluated. Patients with Clavien-Dindo grade V complications, pStage 0, I, or IVB disease, and those who underwent adjuvant radiation therapy were excluded from analysis. Propensity score matching analysis was performed to compare the disease-specific survival (DSS) of patients who underwent adjuvant S-1 chemotherapy with those who underwent observation.RESULTS:Overall, 373/480 patients were eligible, of whom 81 underwent adjuvant S-1 chemotherapy and 146 underwent observation. In the global cohort, DSS was similar in the S-1 and observation groups (p = 0.18), while in the matched cohort (S-1, n = 44; observation, n = 44), DSS was similar between the S-1 and observation groups (p = 0.09). On multivariate analysis, percutaneous biliary drainage (PTBD), CA19-9 levels of ≥ 300 U/mL at operation, and lymph node (LN) metastasis were independent predictors of poor survival following major hepatectomy for PHC. In subgroup analysis of patients with LN metastasis, DSS was better in the S-1 group than in the observation group (p = 0.001).CONCLUSIONS:Adjuvant S-1 chemotherapy following major hepatectomy might be effective in PHC patients with LN metastasis. |
DOI | 10.1245/s10434-024-16546-5 |
PMID | 39623190 |